Pharmacology
Interferon can cause sarcoidosis in patients infected with hepatitis C virus
Published in Hepatitis Weekly, July 7th, 2003
"Interferons have been used as therapy of both malignant and nonmalignant diseases and commonly in the treatment of hepatitis C virus infection. Although the most commonly encountered side effects of interferon therapy include nonspecific constitutional symptoms, pulmonary involvement is rare," investigators in the United States report.
"Here, we provide two documented cases of sarcoidosis appearing in patients receiving interferon therapy for hepatitis C infection, because there have only been a few reports of this association," said A.N. Rubinowitz and colleagues, NYU...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2003-07-07)
More Articles from Hepatitis Weekly
- Hemophilia
HCV-positive hemophiliacs get comprehensive cancer therapy with surveillance - Hepatocellular Carcinoma
Zinc finger transcription factor defines treatment-sensitive liver cancer - Autoimmune Disease
Proper diagnosis and awareness of autoimmune hepatitis compels better survival - Chronic Hepatitis C
Interferon-alpha(2b) induction with ribavirin posts better results against HCV - Hepatology
Obese rats avoid the development of fatty liver with exercise - Blood Safety
Pakistani injection drug users twice as likely to donate blood - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
